Mainspring licenses-commercial software licenses for interfacing to FDA?S science and research investment tracking archive (SARITA)
Ended Awarded Last action
- Contract number
- 75F40122F80168
- Awardee
-
Mainspring, Inc. UEI GHSWFBNZ5EJ4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $47,987
Award facts
- Contract value 100% obligated
- $47,986.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541511 Custom Computer Programming Services
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21701, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$76 | |
| Other Administrative Action | $17,166 | |
| Original award | $30,897 |
About this award
The Food and Drug Administration (FDA) awarded a delivery order valued at $47,986.93 to Mainspring, Inc., a small business contractor based in Frederick, Maryland, on May 31, 2022, with completion scheduled for June 21, 2023. This Total Small Business set-aside award increases the quantity of Mainspring commercial software licenses from 150 to 209 units for interfacing with the FDA's Science and Research Investment Tracking Archive (SARITA). The contract operates under the General Services Administration (GSA) Multiple Award Schedule (MAS) vehicle, utilizing a firm fixed-price delivery order model. Mainspring, an IT strategy and consulting firm specializing in technology solutions and software licensing for federal agencies, has an established relationship with the FDA through prior software license renewals and database support services.
This award represents a routine expansion of the FDA's existing software licensing arrangement with Mainspring, reflecting the agency's continued reliance on the contractor's services to support research tracking and archival operations. The delivery order model and pricing update indicate a modification to an existing GSA MAS contract, allowing the FDA to procure additional licenses and adjust costs without conducting a new competitive solicitation. Mainspring's selection as a small business contractor for this set-aside award aligns with the company's demonstrated capacity to deliver software solutions and maintenance services across multiple federal agencies, including the USDA, CDC, NIH, and National Park Service.
Quick answers
Who was awarded contract 75F40122F80168?
75F40122F80168 was awarded to Mainspring, Inc. by Food and Drug Administration (Department of Health and Human Services) on May 31, 2022.
How much is contract 75F40122F80168 worth?
The government has obligated $47,987 on 75F40122F80168.
Is contract 75F40122F80168 an order under another contract?
Yes. 75F40122F80168 is a delivery order under GS35F363GA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40122F80168 competed?
The extent of competition for 75F40122F80168 was full and open competition. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award